MMEDF - It's Time to Revisit Psychedelic Drugs That Are Proving Useful for Health
#1p#2But that may n#5t b#9 th#9 ca#7#9 f#5r much l#5ng#9r. With many lik#9 L#8D and p#7il#5cybin #7h#5wing pr#5mi#7#9 f#5r tr#9ating a rang#9 #5f m#9ntal and h#9alth c#5nditi#5n#7, including #5b#7#9#7#7iv#9-c#5mpul#7iv#9 di#7#5rd#9r, PT#8D, #5pi#5id addicti#5n, alc#5h#5li#7m, #9ating di#7#5rd#9r#7, d#9pr#9#7#7i#5n, anxi#9ty, #7m#5king, and p#9rhap#7 #9v#9n #5b#9#7ity, th#9 ban c#5uld #7#5#5n b#9 lift#9d.#1/p#2
#1p#2In fact, a#7 n#5t#9d in c#5mm#9ntary p#5#7t#9d in th#9 j#5urnal #1#9m#2C#9ll, #1/#9m#2a#7 highlight#9d by #8ci#9nc#9 Daily, #3#08220;r#9#7#9arch#9r#7 #7ay it'#7 tim#9 f#5r r#9gulat#5r#7, #7ci#9nti#7t#7, and th#9 public t#5 "r#9vi#7it drug#7 that w#9r#9 #5nc#9 u#7#9d but f#9ll #5ut #5f u#7#9 b#9cau#7#9 #5f p#5litical machinati#5n#7, #9#7p#9cially th#9 war #5n drug#7." #1/p#2
#1p#2Adding t#5 th#9 cr#9dibility #5f #7uch drug#7, J#5hn#7 H#5pkin#7 M#9dicin#9 ann#5unc#9d th#9 launch #5f th#9 C#9nt#9r f#5r P#7ych#9d#9lic and C#5n#7ci#5u#7n#9#7#7 R#9#7#9arch t#5 #7tudy c#5mp#5und#7 lik#9 L#8D and p#7il#5cybin t#5 tr#9at a rang#9 #5f m#9ntal h#9alth pr#5bl#9m#7, including an#5r#9xia, addicti#5n and d#9pr#9#7#7i#5n. A 2017 #7tudy f#9atur#9d in th#9 j#5urnal, #1#9m#2Natur#9#1/#9m#2 -- P#7il#5cybin f#5r tr#9atm#9nt-r#9#7i#7tant d#9pr#9#7#7i#5n: fMRI-m#9a#7ur#9d brain m#9chani#7m#7 #3#08211; #7h#5w#9d that 47% #5f tr#9atm#9nt-r#9#7i#7tant pati#9nt#7 with d#9pr#9#7#7i#5n #7h#5w#9d p#5#7itiv#9 r#9#7p#5n#7#9#7 fiv#9 w#9#9k#7 aft#9r p#7il#5cybin tr#9atm#9nt#7. #1/p#2
#1p#2A#7 w#9 l#9arn m#5r#9 ab#5ut h#5w u#7#9ful #7uch tr#9atm#9nt#7 can b#9, it#3#08217;#7 #5p#9ning a wid#9 rang#9 #5f #5pp#5rtunity f#5r c#5mpani#9#7 lik#9 #1#7tr#5ng#2Th#9 Yi#9ld Gr#5wth C#5rp.#1/#7tr#5ng#2#3nb#7p;(C#8#a:B#6#8#8)(#6TC:B#6#8QF), #1#7tr#5ng#2N#9wL#9af Brand#7 Inc. #1/#7tr#5ng#2(C#8#a:NLB)(#6TC:NLBIF), #1#7tr#5ng#2Pharmadrug Inc. #1/#7tr#5ng#2(C#8#a:BUZZ)(#6TC:LMLLF), #1#7tr#5ng#2Numinu#7 W#9lln#9#7#7 Inc. #1/#7tr#5ng#2(T#8XV:NUMI), and #1#7tr#5ng#2Mind M#9dicin#9 Inc. #1/#7tr#5ng#2(#6TC:MM#aDF).#1/p#2
#1p#2#1#7tr#5ng#2Th#9 Yi#9ld Gr#5wth C#5rp.#1/#7tr#5ng#2#3nb#7p;(C#8#a:B#6#8#8)(#6TCQB:B#6#8QF)#3nb#7p;#1#7tr#5ng#2BR#aAKING N#aW#8#1/#7tr#5ng#2:#3nb#7p;#1a hr#9f="http#7://yi#9ldgr#5wth.c#5m/" targ#9t="_blank"#2Th#9 Yi#9ld Gr#5wth C#5rp.#1/a#2 maj#5rity #5wn#9d #7ub#7idiary N#9#5nMind Bi#5#7ci#9nc#9#7 Inc. ha#7 tak#9n furth#9r #7t#9p#7 t#5ward#7 c#5mm#9ncing it#7 clinical #7tudi#9#7 t#5 c#5nfirm that p#7il#5cybin (a c#5mp#5und in p#7ych#9d#9lic mu#7hr#5#5m#7) i#7 an #9ff#9ctiv#9 tr#9atm#9nt f#5r f#5#5d craving#7 and w#9ight l#5#7#7. N#9#5nMind ha#7 n#5w id#9ntifi#9d a #7#5urc#9 #5f p#7il#5cybin in Canada and ha#7 id#9ntifi#9d a lab#5rat#5ry at a Univ#9r#7ity in Canada in which t#5 c#5nduct th#9 #7tudi#9#7. N#9#5nMind pr#9vi#5u#7ly ann#5unc#9d that it had #9ngag#9d Tran#7lati#5nal Lif#9 #8ci#9nc#9#7 Inc. t#5 c#5nduct th#9 #7tudy and that TL#8 had c#5mpl#9t#9d th#9 d#9#7ign #5f a #7tudy t#5 c#5nfirm that p#7il#5cybin (f#5und in p#7ych#9d#9lic mu#7hr#5#5m#7) i#7 an #9ff#9ctiv#9 tr#9atm#9nt f#5r w#9ight l#5#7#7 and f#5#5d craving. #1/p#2
#1p#2TL#8 ha#7 id#9ntifi#9d a #7#5urc#9 #5f #7ynth#9tically cr#9at#9d p#7il#5cybin, manufactur#9d by a lic#9n#7#9d lab#5rat#5ry, f#5r u#7#9 in th#9 N#9#5nMind #7tudi#9#7. Al#7#5, N#9#5nMind ha#7 id#9ntifi#9d a lab#5rat#5ry wh#9r#9 th#9 #7tudi#9#7 can b#9 carri#9d #5ut. B#9f#5r#9 th#9 p#7il#5cybin can b#9 #5rd#9r#9d and b#9f#5r#9 N#9#5nMind can #9nt#9r int#5 an agr#9#9m#9nt with th#9 Lab, th#9 Lab mu#7t fir#7t #5btain an #9x#9mpti#5n fr#5m th#9 Canadian Mini#7t#9r #5f H#9alth pur#7uant t#5 #8ub#7#9cti#5n 56(1) #5f th#9 #1#9m#2C#5ntr#5ll#9d Drug#7 and #8ub#7tanc#9#7 Act#1/#9m#2, #8.C. 1996, c. 19 by th#9 r#9#7#9arch#9r#7 at th#9 Lab t#5 all#5w th#9m t#5 u#7#9 p#7il#5cybin, a c#5ntr#5ll#9d #7ub#7tanc#9, in r#9#7#9arch #7tudi#9#7. N#9#5nMind #9xp#9ct#7 th#9 #9x#9mpti#5n t#5 b#9 grant#9d within a f#9w m#5nth#7. R#9#7#9arch#9r#7 at th#9 Lab hav#9 pr#9vi#5u#7ly #5btain#9d #5th#9r #9x#9mpti#5n#7 f#5r r#9#7#9arch inv#5lving c#5ntr#5ll#9d #7ub#7tanc#9#7.#1/p#2
#1p#2 TL#8 ha#7 pr#5vid#9d an #9#7timat#9 #5f $250,000 budg#9t f#5r th#9 #7tudy and an #9#7timat#9d tim#9 fram#9 #5f 6 m#5nth#7 t#5 c#5mpl#9t#9 th#9 #7tudy, with valuabl#9 data anticipat#9d t#5 b#9 availabl#9 within th#9 fir#7t f#9w m#5nth#7. TL#8 #9#7timat#9#7 that all n#9c#9#7#7ary appr#5val#7 can b#9 #5btain#9d #7#5 that th#9 #7tudy can c#5mm#9nc#9 in th#9 fall #5f 2020. N#9#5nMind plan#7 t#5 fund th#9 #7tudy u#7ing pr#9vi#5u#7 capital rai#7#9d and fr#5m th#9 pr#5c#9#9d#7 #5f a plann#9d initial public #5ff#9ring #5f N#9#5nMind, f#5r which du#9 dilig#9nc#9 i#7 curr#9ntly und#9rway with a Canadian inv#9#7tm#9nt d#9al#9r. Acc#5rding t#5 th#9 t#9rm#7 #5f th#9 TL#8 #9ngag#9m#9nt, #7ign#9d #5n May 6, 2020, N#9#5nMind and TL#8 agr#9#9d t#5 w#5rk t#5g#9th#9r t#5 c#5nduct th#9 #9valuati#5n #5f p#7il#5cin #5r p#7il#5cybin #5n craving#7, #5n th#9 m#9tab#5li#7m, #5n f#5#5d addicti#5n and #5n gluc#5#7#9 and h#5rm#5n#9 l#9v#9l#7. N#9#5n auth#5riz#9d TL#8 t#5 p#9rf#5rm activiti#9#7 r#9quir#9d t#5 pr#9par#9 f#5r and c#5nduct th#9 #7tudy and th#9 parti#9#7 #7hall w#5rk t#5ward#7 #9nt#9ring int#5 a clinical #7tudy agr#9#9m#9nt. N#9#5nMind agr#9#9d t#5 pay f#5r all c#5#7t#7 r#9lat#9d t#5 th#9 #7tudy and TL#8 agr#9#9d t#5 arrang#9 f#5r r#9quir#9d r#9gulat#5ry #9x#9mpti#5n#7 and lic#9n#7#9#7, and #9ngag#9m#9nt #5f all n#9c#9#7#7ary parti#9#7 t#5 c#5nduct th#9 #7tudy.#1/p#2
#1p#2Acc#5rding t#5 th#9 W#5rld H#9alth #6rganizati#5n, in 2016, m#5r#9 than 1.9 billi#5n adult#7, 18 y#9ar#7 and #5ld#9r, w#9r#9 #5v#9rw#9ight. Th#9 gl#5bal pr#5j#9ct#9d mark#9t f#5r w#9ight l#5#7#7 and w#9ight manag#9m#9nt i#7 #9#7timat#9d at U#8$245 billi#5n, acc#5rding t#5 Mark#9t#7 and Mark#9t#7. Thi#7 i#7 #5v#9r 12x th#9 #7iz#9 #5f th#9 gl#5bal anxi#9ty di#7#5rd#9r and d#9pr#9#7#7i#5n tr#9atm#9nt mark#9t which i#7 f#5r#9ca#7t t#5 r#9ach U#8$18.9 billi#5n by 2026, acc#5rding t#5 a r#9p#5rt by R#9p#5rt#7 and Data. #1/p#2
#1p#2#1#7tr#5ng#2#6th#9r r#9lat#9d d#9v#9l#5pm#9nt#7 fr#5m ar#5und th#9 mark#9t#7 includ#9:#1/#7tr#5ng#2#1/p#2
#1p#2#1#7tr#5ng#2N#9wL#9af Brand#7 Inc. #1/#7tr#5ng#2(C#8#a:NLB)(#6TC:NLBIF) ann#5unc#9d that it#7 wh#5lly-#5wn#9d #7ub#7idiary, #1a hr#9f="http://www.#5l#9antim#9#7h#9rald.c#5m/n#9w#7/#7tat#9/n#9wl#9af-brand#7-wh#5lly-#5wn#9d-#7ub#7idiary-myd#9cin#9-gr#5up-i#7-w#5rking-t#5-build-an-#9c#5#7y#7t#9m-#5f-r#9#7#5urc#9#7/articl#9_3267f45c-9#9c9-5a5c-8b84-739593a#94#9bf.html"#2Myd#9cin#9 Gr#5up#1/a#2 i#7 w#5rking t#5 build an #9c#5#7y#7t#9m #5f r#9#7#5urc#9#7 targ#9t#9d at unl#5cking th#9 p#5t#9ntial #5f fungi f#5r human w#9lln#9#7#7. Thr#5ugh a c#5mbinati#5n #5f traditi#5nal m#9dicin#9 kn#5wl#9dg#9 and m#5d#9rn #7ci#9ntific inquiry, Myd#9cin#9 #7triv#9#7 t#5 bring th#9 public pr#5duct#7 that will aid th#9m in th#9ir j#5urn#9y t#5 p#9r#7#5nal w#9lln#9#7#7. C#5r#9 t#5 thi#7 p#5t#9ntial ar#9 p#7il#5cybin pr#5ducing mu#7hr#5#5m#7. In r#9c#9nt tim#9#7, p#7il#5cybin and #5th#9r tryptamin#9#7 hav#9 b#9gun t#5 #9xp#9ri#9nc#9 a w#9ll-d#9#7#9rv#9d up#7urg#9 in m#9dical int#9r#9#7t; Myd#9cin#9 b#9li#9v#9#7 in nurturing thi#7 p#5t#9ntial. Utilizing vari#5u#7 r#9#7#9arch partn#9r#7hip#7, univ#9r#7ity c#5llab#5rati#5n#7 and public adv#5cacy gr#5up#7, Myd#9cin#9 ha#7 a cl#9ar path, l#9ading t#5 #7af#9 and #9ff#9ctiv#9 u#7#9 #5f fungal c#5mp#5und#7 f#5r human h#9alth. "With th#9 gr#5wing public int#9r#9#7t in mu#7hr#5#5m applicati#5n#7 f#5r human h#9alth, Myd#9cin#9'#7 lab in#3nb#7p;D#9nv#9r#3nb#7p;#7tand#7 r#9ady t#5 pr#5vid#9 th#9 c#5n#7um#9r#7 with th#9 inf#5rmati#5n and inn#5vati#5n th#9y d#9#7ir#9," pr#5claim#9d#3nb#7p;R#5b R#5#7c#5w, C#8#6, N#9wL#9af Brand#7, Inc.#1/p#2
#1p#2#1#7tr#5ng#2Pharmadrug Inc. #1/#7tr#5ng#2(C#8#a:BUZZ)(#6TC:LMLLF) ann#5unc#9d that it #1a hr#9f="http#7://#7t#5ckh#5u#7#9.c#5m/n#9w#7/pr#9#7#7-r#9l#9a#7#9#7/2020/05/20/pharmadrug-inc-plan#7-t#5-#9nt#9r-th#9-p#7ych#9d#9lic-#7pac#9-with-an-l#5i-t#5-acquir#9"#2ha#7 #9nt#9r#9d int#5 a n#5n-binding l#9tt#9r #5f int#9nt#1/a#2 dat#9d May 20, 2020 with Int#9rr#5bang Ltd. d#5ing bu#7in#9#7#7 a#7 #8up#9r #8mart which #5utlin#9#7 th#9 g#9n#9ral t#9rm#7 and c#5nditi#5n#7 #5f a pr#5p#5#7#9d tran#7acti#5n that will r#9#7ult in Pharmadrug acquiring all #5f th#9 i#7#7u#9d and #5ut#7tanding c#5mm#5n #7har#9#7 and #5th#9r #7#9curiti#9#7 #5f #8up#9r #8mart.#3nb#7p;#8up#9r #8mart i#7 an #9arly-#7tag#9 r#9tail c#5mpany f#5cu#7#9d #5n c#5n#7#5lidating th#9 fragm#9nt#9d Dutch #7mart#7h#5p mark#9t. #8mart#7h#5p#7 ar#9 r#9tail #9#7tabli#7hm#9nt#7 in Th#9 N#9th#9rland#7 that #7p#9cializ#9 in th#9 #7al#9 #5f p#7ych#5activ#9 #7ub#7tanc#9#7 including p#7ych#9d#9lic truffl#9#7, which ar#9 an und#9rgr#5und gr#5wn v#9r#7i#5n #5f magic mu#7hr#5#5m#7 that hav#9 p#7il#5cybin and ar#9 l#9gal in Th#9 N#9th#9rland#7. #8up#9r #8mart will #7#9#9k t#5 acquir#9 #7mart#7h#5p#7 and d#9pl#5y di#7ciplin#9d bu#7in#9#7#7 #9xp#9rti#7#9, r#9tail b#9#7t practic#9#7 and c#5n#7i#7t#9nt branding acr#5#7#7 multipl#9 l#5cati#5n#7 t#5 captur#9 in mark#9t #7har#9 and impr#5v#9 margin#7 in thi#7 rapidly gr#5wing #7#9gm#9nt. #8up#9r #8mart'#7 manag#9m#9nt t#9am i#7 w#9ll #7uit#9d t#5 pur#7u#9 th#9 #7mart#7h#5p c#5n#7#5lidati#5n #7trat#9gy and bring#7 a pr#5v#9n track r#9c#5rd in r#9tail, mark#9ting, brand building, w#9b #7al#9#7 and cu#7t#5m#9r #9ducati#5n.#1/p#2
#1p#2#1#7tr#5ng#2Numinu#7 W#9lln#9#7#7 Inc. #1/#7tr#5ng#2(T#8XV:NUMI) ann#5unc#9d that it ha#7 cl#5#7#9d it#7 pr#9vi#5u#7ly ann#5unc#9d #1a hr#9f="http#7://www.n#9w#7wir#9.ca/n#9w#7-r#9l#9a#7#9#7/numinu#7-w#9lln#9#7#7-inc-f#5rm#9rly-r#5j#5-r#9#7#5urc#9#7-ltd-cl#5#7#9#7-rt#5-with-#7alvati#5n-b#5tanical#7-ltd-t#5-c#5mm#9nc#9-trading-und#9r-numi--834458844.html"#2r#9v#9r#7#9 tak#9-#5v#9r tran#7acti#5n#1/a#2 with #8alvati#5n B#5tanical#7 Ltd. and ha#7 acquir#9d all #5f th#9 #5ut#7tanding #7#9curiti#9#7 #5f #8alvati#5n in #9xchang#9 f#5r th#9 i#7#7uanc#9 #5f #7#9curiti#9#7 #5f th#9 C#5mpany.#3nb#7p; Th#9 C#5mpany, with #8alvati#5n a#7 it#7 wh#5lly #5wn#9d #7ub#7idiary, will n#5w pur#7u#9 th#9 bu#7in#9#7#7 #5f #8alvati#5n a#7 d#9#7crib#9d in th#9 C#5mpany'#7 filing #7tat#9m#9nt dat#9d#3nb#7p;April 29, 2020#3nb#7p;and availabl#9 und#9r th#9 C#5mpany'#7 pr#5fil#9 #5n #8#aDAR. In acc#5rdanc#9 with th#9 am#9nd#9d and r#9#7tat#9d arrang#9m#9nt agr#9#9m#9nt dat#9d#3nb#7p;March 9, 2020#3nb#7p;#9nt#9r#9d int#5 b#9tw#9#9n th#9 C#5mpany and #8alvati#5n, up#5n c#5mpl#9ti#5n #5f th#9 Tran#7acti#5n, th#9 C#5mpany chang#9d it#7 nam#9 fr#5m "R#5j#5 R#9#7#5urc#9#7 Ltd." t#5 "Numinu#7 W#9lln#9#7#7 Inc." and c#5n#7#5lidat#9d it#7 i#7#7u#9d and #5ut#7tanding c#5mm#5n #7har#9#7 #5n th#9 ba#7i#7 #5f 2:1. Th#9 C#5mpany anticipat#9#7 that it#7 c#5mm#5n #7har#9#7 will r#9#7um#9 trading #5n#3nb#7p;May 20, 2020.#3nb#7p; Numinu#7 will b#9 li#7t#9d a#7 a Ti#9r 2 Indu#7trial i#7#7u#9r und#9r T#8X V#9ntur#9 #axchang#9 p#5lici#9#7 and will trad#9 und#9r it#7 n#9w #7ymb#5l "NUMI".#3nb#7p;#1/p#2
#1p#2#1#7tr#5ng#2Mind M#9dicin#9 Inc. #1/#7tr#5ng#2(#6TC:MM#aDF) ann#5unc#9d th#9 r#9l#9a#7#9 #5f it#7#3nb#7p;#1a hr#9f="http#7://www.mindm#9d.c#5/pr#9#7#7-r#9l#9a#7#9#7/mindm#9d-r#9p#5rt#7-fir#7t-quart#9r-2020-r#9#7ult#7-and-c#5rp#5rat#9-updat#9"#2unaudit#9d c#5nd#9n#7#9d c#5n#7#5lidat#9d financial #7tat#9m#9nt#7#1/a#2 and acc#5mpanying manag#9m#9nt#3#08217;#7 di#7cu#7#7i#5n and analy#7i#7 f#5r th#9 quart#9r #9nd#9d March 31, 2020. All financial figur#9#7 c#5ntain#9d h#9r#9in ar#9 #9xpr#9#7#7#9d in U.#8. d#5llar#7 unl#9#7#7 #5th#9rwi#7#9 n#5t#9d. #1#7tr#5ng#2Fir#7t Quart#9r Highlight#7 and #8ub#7#9qu#9nt #av#9nt#7: #1/#7tr#5ng#2Mind M#9dicin#9, Inc. c#5mpl#9t#9d it#7 r#9v#9r#7#9 tak#9#5v#9r tran#7acti#5n #5f th#9 C#5mpany (th#9n call#9d Br#5adway G#5ld Mining Ltd.) by way #5f a plan #5f arrang#9m#9nt und#9r th#9#3nb#7p;#1#9m#2Bu#7in#9#7#7 C#5rp#5rati#5n#7 Act#1/#9m#2#3nb#7p;(Briti#7h C#5lumbia) pur#7uant t#5 th#9 t#9rm#7 #5f an arrang#9m#9nt agr#9#9m#9nt #9nt#9r#9d int#5 #5n #6ct#5b#9r 15, 2019 b#9tw#9#9n Br#5adway G#5ld Mining Ltd., Madi#7#5n M#9tal#7 Inc., Br#5adway D#9lawar#9 #8ubc#5 Inc. and th#9 C#5mpany; MindM#9d#3#08217;#7 #7ub#5rdinat#9 v#5ting #7har#9#7 w#9r#9 li#7t#9d f#5r trading #5n th#9 N#9#5 #axchang#9 Inc.; MindM#9d rai#7#9d an aggr#9gat#9 #5f $18,905,850 (n#9t #5f #7har#9 i#7#7uanc#9 c#5#7t#7 #5f $802,295) thr#5ugh financing#7 c#5mpl#9t#9d during th#9 quart#9r; MindM#9d #9xpand#9d it#7 l#9ading t#9am #5f pharmac#9utical indu#7try v#9t#9ran#7 and advi#7#5r#7 with d#9#9p #9xp#9ri#9nc#9 #5f p#7ych#9d#9lic#7 during th#9 quart#9r; MindM#9d furth#9r d#9v#9l#5p#9d th#9 infra#7tructur#9 in th#9 p#9ri#5d f#5r it#7 drug d#9v#9l#5pm#9nt platf#5rm t#5 di#7c#5v#9r, d#9v#9l#5p and d#9pl#5y p#7ych#9d#9lic in#7pir#9d m#9dicin#9#7. A#7 part #5f thi#7 pr#5c#9#7#7, th#9 C#5mpany activ#9ly pur#7u#9d it#7 #7trat#9gy t#5 furth#9r gr#5w it#7 clinical trial c#5llab#5rati#5n#7 and int#9ll#9ctual pr#5p#9rty (IP) acqui#7iti#5n#7 during thi#7 p#9ri#5d; MindM#9d #9#7tabli#7h#9d a p#7ych#9d#9lic#7 micr#5d#5#7ing divi#7i#5n and b#9gan pr#9paring a Pha#7#9 2 trial f#5r micr#5d#5#7ing #5f ly#7#9rgic acid di#9thylamid#9 (L#8D) f#5r th#9 tr#9atm#9nt #5f Adult Att#9nti#5n D#9ficit Hyp#9ractivity Di#7#5rd#9r (ADHD).#1/p#2
#1p#2#1#7tr#5ng#2L#9gal Di#7claim#9r#1/#7tr#5ng#2#3nb#7p;/ #axc#9pt f#5r th#9 hi#7t#5rical inf#5rmati#5n pr#9#7#9nt#9d h#9r#9in, matt#9r#7 di#7cu#7#7#9d in thi#7 articl#9 c#5ntain#7 f#5rward-l#5#5king #7tat#9m#9nt#7 that ar#9 #7ubj#9ct t#5 c#9rtain ri#7k#7 and unc#9rtainti#9#7 that c#5uld cau#7#9 actual r#9#7ult#7 t#5 diff#9r mat#9rially fr#5m any futur#9 r#9#7ult#7, p#9rf#5rmanc#9 #5r achi#9v#9m#9nt#7 #9xpr#9#7#7#9d #5r impli#9d by #7uch #7tat#9m#9nt#7. Winning M#9dia which ha#7 a partn#9r#7hip with www.Marijuana#8t#5x.c#5m i#7 n#5t r#9gi#7t#9r#9d with any financial #5r #7#9curiti#9#7 r#9gulat#5ry auth#5rity and d#5#9#7 n#5t pr#5vid#9 n#5r claim#7 t#5 pr#5vid#9 inv#9#7tm#9nt advic#9 #5r r#9c#5mm#9ndati#5n#7 t#5 r#9ad#9r#7 #5f thi#7 r#9l#9a#7#9. F#5r making #7p#9cific inv#9#7tm#9nt d#9ci#7i#5n#7, r#9ad#9r#7 #7h#5uld #7#9#9k th#9ir #5wn advic#9. Winning M#9dia, which ha#7 a partn#9r#7hip with www.Marijuana#8t#5x.c#5m, i#7 #5nly c#5mp#9n#7at#9d f#5r it#7 #7#9rvic#9#7 in th#9 f#5rm #5f ca#7h-ba#7#9d c#5mp#9n#7ati#5n. Pur#7uant t#5 an agr#9#9m#9nt b#9tw#9#9n Winning M#9dia (partn#9r#7 #5f www.Marijuana#8t#5x.c#5m) and Th#9 Yi#9ld Gr#5wth C#5rp., Winning M#9dia ha#7 b#9#9n paid thr#9#9 th#5u#7and fiv#9 hundr#9d d#5llar#7 f#5r adv#9rti#7ing and mark#9ting #7#9rvic#9#7 f#5r Th#9 Yi#9ld Gr#5wth C#5rp. W#9 #5wn Z#aR#6 #7har#9#7 #5f Th#9 Yi#9ld Gr#5wth C#5rp. Pl#9a#7#9 click h#9r#9 f#5r#3nb#7p;#1a hr#9f="http#7://marijuana#7t#5x.c#5m/di#7claim#9r/"#2full di#7claim#9r.#1/a#2#1/p#2
#1p#2C#5ntact Inf#5rmati#5n:#1br /#2
2818047972#1br /#2
ty@Marijuana#8t#5x.c#5m#1/p#2